Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRESS-L
2017-001785-14Phase 2Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of landiolol in septic shock, sponsored by University Hospitals Birmingham. Primary endpoint: Mean SOFA score over first 14 days. Status: unknown.
02
Drugs
landiolol
03
Conditions
septic shock
Beyond the preview
Go deeper on 2017-001785-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001785-14.